Takeshi Kawarabayashi Selected Research

Polyneuropathies (Polyneuropathy)

3/2019	Severe Chronic Inflammatory Demyelinating Polyneuropathy Ameliorated following High-dose (3 g/kg) Intravenous Immunoglobulin Therapy.
11/2010	Quantification of cystatin C in cerebrospinal fluid from various neurological disorders and correlation with G73A polymorphism in CST3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takeshi Kawarabayashi Research Topics

Disease

24	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 02/2002
7	Tauopathies 01/2023 - 06/2006
7	Amyloidosis 01/2023 - 04/2004
4	Parkinson Disease (Parkinson's Disease) 11/2010 - 08/2008
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 11/2009
3	Memory Disorders (Memory Loss) 03/2011 - 03/2002
3	Synucleinopathies 11/2009 - 08/2007
2	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 03/2019 - 11/2010
2	Polyneuropathies (Polyneuropathy) 03/2019 - 11/2010
2	Multiple System Atrophy 01/2019 - 11/2010
2	Down Syndrome (Down's Syndrome) 08/2007 - 08/2004
1	Body Weight (Weight, Body) 01/2023
1	Atherosclerosis 01/2023
1	Hypophysitis 09/2021
1	Infarction (Infarctions) 12/2020
1	Pathologic Constriction (Stenosis) 12/2020
1	Dementia (Dementias) 01/2020
1	Quadriplegia (Spastic Quadriplegia) 03/2019
1	Respiratory Insufficiency (Respiratory Failure) 03/2019
1	Muscle Weakness 03/2019
1	Brain Diseases (Brain Disorder) 01/2019
1	Hereditary Myopathy with Early Respiratory Failure 05/2015
1	Nervous System Diseases (Neurological Disorders) 11/2010
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2010
1	Lymphoma (Lymphomas) 01/2009
1	Necrosis 01/2009
1	Osteomyelitis 01/2009
1	Tetanus 01/2009
1	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 01/2008
1	Frontotemporal Dementia (Semantic Dementia) 02/2005

Drug/Important Bio-Agent (IBA)

11	Amyloid (Amyloid Fibrils)IBA 01/2023 - 03/2002
9	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2002
4	Amyloid beta-PeptidesIBA 05/2008 - 04/2004
3	alpha-SynucleinIBA 11/2009 - 08/2007
3	Presenilin-1IBA 08/2007 - 03/2002
2	Threonine (L-Threonine)FDA Link 01/2023 - 01/2020
2	LipidsIBA 01/2022 - 04/2004
2	SteroidsIBA 09/2021 - 03/2019
2	Indicators and Reagents (Reagents)IBA 12/2020 - 11/2009
2	Lipoproteins (Lipoprotein)IBA 06/2011 - 08/2004
2	AntibodiesIBA 07/2008 - 06/2008
2	Proteins (Proteins, Gene)FDA Link 10/2002 - 03/2002
1	Triglycerides (Triacylglycerol)IBA 01/2023
1	Apolipoprotein E2IBA 01/2023
1	Apolipoprotein E4IBA 01/2023
1	Apolipoprotein E3IBA 01/2023
1	Insulin (Novolin)FDA Link 01/2023
1	HDL CholesterolIBA 01/2023
1	LDL CholesterolIBA 01/2023
1	Contrast MediaIBA 09/2021
1	EnzymesIBA 01/2020
1	ImmunosorbentsIBA 01/2020
1	tau Proteins (tau Protein)IBA 01/2020
1	Intravenous Immunoglobulins (IVIG)FDA Link 03/2019
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2019
1	SynucleinsIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 05/2015
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 04/2011
1	Apolipoproteins D (Apo D)IBA 04/2011
1	Coloring Agents (Dyes)IBA 11/2010
1	LatexIBA 11/2010
1	Cystatin CIBA 11/2010
1	Metronidazole (Metric)FDA LinkGeneric 01/2009
1	Prealbumin (Transthyretin)IBA 01/2009
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2009
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 08/2008
1	Levodopa (L Dopa)FDA LinkGeneric 08/2008
1	Scavenger Receptors (Scavenger Receptor)IBA 06/2008
1	Genetic Markers (Genetic Marker)IBA 05/2008
1	Cerebroside-Sulfatase (Arylsulfatase A)IBA 01/2008
1	Peptide Initiation Factors (Initiation Factor)IBA 06/2006
1	Prion ProteinsIBA 02/2005
1	ApolipoproteinsIBA 04/2004
1	Cholinergic Agents (Cholinergics)IBA 04/2004
1	Acetylcholine (Acetylcholine Chloride)FDA Link 04/2004
1	Monoclonal AntibodiesIBA 08/2002
1	Flavin-Adenine Dinucleotide (FAD)IBA 03/2002
1	Detergents (Detergent)IBA 03/2002
1	CholesterolIBA 02/2002

Therapy/Procedure

5	Therapeutics 09/2021 - 01/2009
1	Plasma Exchange 03/2019
1	Radiotherapy 01/2009
1	Injections 01/2009